查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1718229

Fentanyl市場 - 全球預測 2025-2030

Fentanyl Market by Product Type, Route of Administration, Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2024年Fentanyl市場價值將達23.6億美元，2025年將達24.7億美元，複合年成長率為4.66%，到2030年將達到31.1億美元。

主要市場統計數據
基準年2024年 23.6億美元
預計2025年 24.7億美元
預測年份 2030 31.1億美元
複合年成長率（%） 4.66%

在快速變化的製藥業中，Fentanyl市場因臨床需求和法律規範之間的複雜相互作用而受到廣泛關注。近年來，在創新醫療應用和日益成長的研究舉措的推動下，這一領域經歷了重大變化。Fentanyl使用的動態性質反映了更廣泛的趨勢，包括不斷變化的患者需求、正在進行的臨床試驗以及對安全性和有效性標準的認知的提高。這個多邊市場現在需要仔細重新考慮定價壓力、競爭差異化和技術進步的快速步伐。

日益嚴格的審查迫使產業負責人不僅要關注藥物傳遞的傳統方面，還要關注將影響疼痛管理、麻醉和臨終關懷未來的變革性變化。本研究深入檢驗了影響Fentanyl發展軌跡的關鍵市場促進因素、挑戰和機會。我們的分析著重可靠的數據、關鍵見解和策略預測，深入研究細微的市場動態和新興的法律規範，為決策者和行業專業人士提供全面的觀點。透過將這些關鍵問題置於更廣泛的背景中，本報告旨在成為日益激烈的競爭環境中明智的決策的權威指南和催化劑。

Fentanyl市場的轉型

Fentanyl市場的發展具有一系列變革性變化的特點，強調適應新的臨床、監管和技術促進因素。近年來，創新藥物輸送系統和加強安全通訊協定的投資不斷增加，導致研究重點明顯調整，市場動態也發生轉變。先進配方和替代給藥途徑的引入不僅拓寬了治療應用，而且還為改善患者依從性和治療效果提供了途徑。

政策改革和更嚴格的法規環境正在促使公司重新調整策略，特別是在謹慎管理醫療用途和潛在濫用之間的平衡方面。對永續供應鏈和品質保證的重新重視正在推動市場參與企業投資於尖端製造流程和風險緩解技術。這種持續的演變鼓勵相關人員採用新技術並加強夥伴關係，同時培養一個創新與負責任使用並進的生態系統。

這些發展反映出該行業越來越傾向於精準驅動的應用，並擴大範圍以考慮整個病人歷程。隨著醫療保健專業人員和創新者繼續合作，整體效果將是一個更靈活、反應更快的市場，更適合滿足即時的臨床需求和長期趨勢。

推動市場動態的關鍵細分洞察

仔細觀察市場就會發現，多層次的細分凸顯了Fentanyl市場的多樣性與專業化。根據產品類型，正在考慮多種劑型，從注射劑到創新的錠劑和錠劑，以及滴鼻劑和經皮吸收貼片。產品的多樣性使醫療專業人員能夠針對不同的臨床情況選擇最佳解決方案，無論是即時介入還是持續照護。

就給藥途徑而言，市場分為口服、腸外和經皮途徑。每條道路都有其自身的優勢和挑戰，這將影響整體市場佔有率和創新重點。此外，在應用細分方面，分析分為醫療和研發兩大領域。在醫療用途方面，它進一步細分為麻醉、疼痛管理和安寧療護等重要子類別，突顯了藥物在臨床環境中的多功能性。

最後，了解分銷管道將突出在醫院、藥局和零售藥局等各個關鍵點進行的研究。這種強大的細分框架不僅揭示了特定的市場促進因素，而且還支持更有針對性的策略規劃和有針對性的投資。它還有助於深入了解每個環節如何為整個價值鏈做出貢獻，使相關人員能夠根據精細的消費者和臨床需求發現成長、創新和夥伴關係的機會。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 慢性疼痛的發生率不斷上升，對有效疼痛管理的需求也日益增加
      • 術後和急性護理環境中對強效疼痛管理解決方案的需求不斷增加
      • 增加醫療保健投資和政府措施以改善疼痛管理
    • 限制因素
      • 與Fentanyl相關的監管調查和公共衛生問題
    • 機會
      • 引進預填充式注射器，方便隨時給藥
      • 開發防止濫用的Fentanyl製劑，以提高安全性並擴大醫療用途
    • 任務
      • Fentanyl的非法生產和分銷
  • 市場區隔分析
    • 產品類型：注射劑因其快速起效的特性而日益普及
    • 給藥途徑：口服給藥是治療慢性疼痛的首選非侵入性方法
    • 分銷管道：醫院藥房Fentanyl在急性和手術全期疼痛管理的應用
    • 用途：擴大Fentanyl的醫療用途，芬太尼具有快速起效和強效止痛的特性
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章Fentanyl市場（依產品類型）

  • 介紹
  • 注射
  • 錠劑和錠劑
  • 鼻噴劑
  • 修補

第7章Fentanyl市場（依給藥途徑）

  • 介紹
  • 口服
  • 腸外
  • 經皮

第8章Fentanyl市場（按應用）

  • 介紹
  • 醫療用途
    • 麻醉
    • 疼痛管理
    • 安寧療護
  • 研究與開發

第9章Fentanyl市場通路

  • 介紹
  • 醫院藥房
  • 零售藥局

10.美洲Fentanyl市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

11. 亞太地區Fentanyl市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

12. 歐洲、中東和非洲Fentanyl市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Alvogen
  • Apotex Inc.
  • Biesterfeld SE
  • Daiichi Sankyo Company, Limited
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals PLC
  • Humanwell Healthcare（Group）Co., Ltd.
  • Kyowa Hakko Kirin Co. Ltd.
  • Mallinckrodt plc
  • Nutriband Inc.
  • Pfizer Inc.
  • Piramal Pharma Limited
  • QuVa Pharma, Inc
  • SCA Pharma
  • Spectrum Chemical Mfg. Corp.
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Tofigh Daru Research & Engineering Company
  • Verve HumanCare Laboratories
  • Viatris Inc.
Product Code: MRR-CB04E056533E

The Fentanyl Market was valued at USD 2.36 billion in 2024 and is projected to grow to USD 2.47 billion in 2025, with a CAGR of 4.66%, reaching USD 3.11 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.36 billion
Estimated Year [2025] USD 2.47 billion
Forecast Year [2030] USD 3.11 billion
CAGR (%) 4.66%

In the ever-evolving world of pharmaceuticals, the fentanyl market has garnered significant attention due to its complex interplay between clinical demand and regulatory oversight. Over recent years, this sector has experienced considerable shifts driven by both innovative medical applications and growing research initiatives. The dynamic nature of fentanyl usage reflects broader trends that include evolving patient needs, ongoing clinical trials, and heightened awareness of safety and efficacy standards. This multifaceted market now demands a careful reexamination of price pressures, competitive differentiation, and the rapid pace of technological advancements.

Amid heightened scrutiny, industry researchers are tasked with exploring not only the conventional aspects of drug delivery but also the transformative shifts shaping the future of pain management, anesthesia, and end-of-life care. This study provides a meticulous examination of key market drivers, challenges, and opportunities that currently influence the trajectory of fentanyl. Emphasizing reliable data, critical insights, and strategic forecasts, the analysis delves into nuanced market dynamics and emerging regulatory frameworks to offer a comprehensive perspective for decision-makers and industry experts. By framing these key issues within a broader context, this report aims to serve as both a definitive guide and a catalyst for informed decision-making in an increasingly competitive landscape.

Transformative Shifts in the Fentanyl Market Landscape

The evolving nature of the fentanyl market has been marked by a series of transformative shifts that underscore its adaptation to new clinical, regulatory, and technological drivers. In recent years, there has been a discernible realignment of research focus and a shift in market dynamics fueled by increasing investments in innovative drug delivery systems and enhanced safety protocols. The introduction of advanced formulations and alternative routes of administration has not only broadened therapeutic applications but has also provided avenues for improved patient compliance and outcomes.

Policy reforms and a more rigorous regulatory environment have spurred companies to recalibrate their strategies, especially as the balance between medical use and potential misuse is carefully managed. With a renewed emphasis on sustainable supply chains and quality assurance, market participants are now investing in state-of-the-art manufacturing processes and risk mitigation techniques. This ongoing evolution has pushed stakeholders to embrace novel technologies and robust partnerships, while also fostering an ecosystem where innovation and responsible use go hand in hand.

These developments reflect an industry increasingly inclined toward precision-based applications and an expanded scope that takes into account the entirety of the patient journey. As practitioners and innovators continue to work in tandem, the overall impact is a more agile, responsive market that is better equipped to tackle both immediate clinical needs and long-term trends.

Key Segmentation Insights Driving Market Dynamics

A detailed examination of the market reveals several layers of segmentation that highlight both the diversity and specialization within the fentanyl sector. The product type segmentation examines formulations ranging from injectables to innovative lozenges and tablets, alongside nasal sprays and transdermal patches - each reflecting unique delivery mechanisms tailored to distinct therapeutic needs. This spectrum of products enables healthcare professionals to choose solutions that best fit different clinical scenarios, whether for immediate intervention or sustained care.

When looking at the route of administration, the market is dissected across oral, parenteral, and transdermal pathways. Each method carries its own set of benefits and challenges, influencing the overall market share and innovation focus. Additionally, the application segmentation bifurcates the analysis into medical use and research and development. Within medical use, there is a further breakdown into critical sub-categories including anesthesia, pain management, and palliative care, underlining the drug's versatility in clinical settings.

Finally, an understanding of the distribution channel reveals studies conducted across various critical points including hospitals, pharmacies, and retail pharmacies. This robust segmentation framework not only sheds light on specific market drivers but also supports more tailored strategic planning and targeted investment. It facilitates insight into how each segment contributes to the overall value chain, enabling stakeholders to identify opportunities for growth, innovation, and partnership based on refined consumer and clinical needs.

Based on Product Type, market is studied across Injectables, Lozenges & Tablets, Nasal Sprays, and Patches.

Based on Route of Administration, market is studied across Oral, Parenteral, and Transdermal.

Based on Application, market is studied across Medical Use and Research & Development. The Medical Use is further studied across Anesthesia, Pain Management, and Palliative Care.

Based on Distribution Channel, market is studied across Hospitals Pharmacies and Retail Pharmacies.

Key Regional Insights Shaping Market Opportunities

Geographic analysis of the fentanyl market demonstrates distinct regional nuances that are instrumental in shaping both current dynamics and future opportunities. In the Americas, the market has shown a progressive shift driven by advanced healthcare infrastructure and evolving treatment protocols, which in turn have spurred rapid adoption of new formulations and innovative delivery methods. Regulatory frameworks in these regions support a robust yet controlled market environment, ensuring that clinical efficacy and safety remain paramount.

The landscape in Europe, the Middle East, and Africa underscores a complex interplay between established healthcare systems and emerging markets. In these regions, traditional healthcare practices are increasingly complemented by cutting-edge technologies and research-driven innovations. This blend of historical strength and novel approaches has led to renewed interest in comprehensive market strategies. Similarly, the Asia-Pacific area, characterized by accelerated economic development and increasing healthcare spending, has emerged as a significant player. Rapid urbanization, enhanced patient access, and expanding clinical capabilities have all contributed to a dynamic market environment. The regional insights provide a holistic view of how local socio-economic factors and regulatory policies can drive both competition and collaboration on a global scale.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights and Industry Leaders

The fentanyl market is not only defined by evolving therapeutic areas and product innovation, but also by a competitive landscape dominated by a cohort of established industry players. In this arena, several companies have distinguished themselves by offering proprietary technologies and streamlined operations. Leading companies ranging from global innovators to specialized firms have propelled the momentum of the market through strategic investments in R&D and robust commercial networks. These include players such as Alvogen, Apotex Inc., Biesterfeld SE, and Daiichi Sankyo Company, Limited, whose commitment to research and comprehensive clinical adoption has fostered progress across the board.

Additional industry trailblazers like Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, and Humanwell Healthcare (Group) Co., Ltd. have contributed significantly to shaping the market through their persistent focus on innovation and quality improvement. This competitive group is further enriched by the presence of companies such as Kyowa Hakko Kirin Co. Ltd., Mallinckrodt plc, Nutriband Inc., and Pfizer Inc., each bringing a unique perspective and diversified portfolio to the field. Noteworthy efforts by Piramal Pharma Limited, QuVa Pharma, Inc., SCA Pharma, Spectrum Chemical Mfg. Corp., Terumo Corporation, Teva Pharmaceutical Industries Ltd., Tofigh Daru Research & Engineering Company, Verve HumanCare Laboratories, and Viatris Inc. also highlight an industry driven by vigorous competition, technological advancements, and an unwavering commitment to quality. Together, these companies not only shape market standards but also stimulate an environment of continuous improvement and strategic realignment.

The report delves into recent significant developments in the Fentanyl Market, highlighting leading vendors and their innovative profiles. These include Alvogen, Apotex Inc., Biesterfeld SE, Daiichi Sankyo Company, Limited, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, Humanwell Healthcare (Group) Co., Ltd., Kyowa Hakko Kirin Co. Ltd., Mallinckrodt plc, Nutriband Inc., Pfizer Inc., Piramal Pharma Limited, QuVa Pharma, Inc, SCA Pharma, Spectrum Chemical Mfg. Corp., Terumo Corporation, Teva Pharmaceutical Industries Ltd., Tofigh Daru Research & Engineering Company, Verve HumanCare Laboratories, and Viatris Inc.. Actionable Recommendations for Industry Leaders in Fentanyl

For industry leaders seeking to navigate the complexities of the fentanyl market and harness growth opportunities, several actionable recommendations stand out. First and foremost, it is crucial to maintain a proactive approach by investing in innovative delivery systems and advanced formulation technologies. Empowering research initiatives can lead to more efficacious and safer therapeutic options that meet stringent clinical requirements and regulatory standards.

Leaders should also focus on bolstering their presence across key distribution channels. Strategic alliances with hospitals, pharmacies, and retail networks can ensure broader market penetration and diversified revenue streams. In addition, a continuous review of product portfolios - especially with respect to different routes of administration such as oral, parenteral, and transdermal - can yield insights that align clinical performance with market expectations.

A sharp focus on regional dynamics is equally critical. With distinctive market conditions in the Americas, Europe, the Middle East & Africa, and Asia-Pacific, tailored regional strategies are essential. Investment in localized research and market-specific promotions helps in addressing unique consumer demands and regulatory challenges. Finally, fostering collaborative partnerships across the value chain, from R&D to distribution, will not only drive innovation but also create sustainable competitive advantages in an increasingly dynamic environment. These recommendations, when implemented effectively, can serve as a robust framework to enhance market positioning and drive long-term growth.

Conclusion: Strategic Reflections on Fentanyl Market Trends

In summary, the analysis of the fentanyl market underscores a period of significant transformation marked by dynamic innovation, evolving regulatory frameworks, and an increasingly segmented market structure. The interplay between advanced drug formulations, sophisticated routes of administration, and diversified applications has fueled a vibrant competitive landscape. Regional variations further accentuate differences in market maturity, offering unique insights into both growth potentials and strategic challenges that span global markets.

This comprehensive review highlights the necessity for industry stakeholders to adopt forward-looking strategies that balance innovation with prudent risk management. The evolving nature of clinical needs, paired with rapid technological advancements, calls for a persistent reevaluation of market strategies to meet the demands of a complex healthcare environment. Ultimately, this reflective overview serves as a call to industry leaders to embrace change and pursue opportunities that align with emerging trends and consumer expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of chronic pain conditions with the need for effective pain management
      • 5.1.1.2. Growing demand for potent pain management solutions in post-surgical and acute care settings
      • 5.1.1.3. Increased healthcare investments and government initiatives aimed at improving pain management
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory scrutiny and public health concerns associated with fentanyl
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of ready-to-administer prefilled fentanyl syringes
      • 5.1.3.2. Development of abuse-deterrent fentanyl formulations to enhance safety and expand medical use
    • 5.1.4. Challenges
      • 5.1.4.1. Illicit production and distribution of fentanyl
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing adoption of injectables due to their immediate onset of action
    • 5.2.2. Route of Administration: Preference for oral route of administration for non-invasive option for chronic pain management
    • 5.2.3. Distribution Channel: Utilization of fentanyl in hospitals pharmacies in managing acute and perioperative pain
    • 5.2.4. Application: Expanding application of fentanyl in medical use for its rapid onset and potent analgesic properties.
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fentanyl Market, by Product Type

  • 6.1. Introduction
  • 6.2. Injectables
  • 6.3. Lozenges & Tablets
  • 6.4. Nasal Sprays
  • 6.5. Patches

7. Fentanyl Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Oral
  • 7.3. Parenteral
  • 7.4. Transdermal

8. Fentanyl Market, by Application

  • 8.1. Introduction
  • 8.2. Medical Use
    • 8.2.1. Anesthesia
    • 8.2.2. Pain Management
    • 8.2.3. Palliative Care
  • 8.3. Research & Development

9. Fentanyl Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals Pharmacies
  • 9.3. Retail Pharmacies

10. Americas Fentanyl Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Fentanyl Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Fentanyl Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Nephron Pharmaceuticals invests USD 10 million to expand BFS manufacturing capacity for advanced drug formulations
    • 13.3.2. Hikma Pharmaceuticals introduces new fentanyl citrate injections for advanced pain management in clinical settings
    • 13.3.3. The University of Montana and corporate partners advance NIH-funded preclinical studies on novel fentanyl and heroin vaccines
    • 13.3.4. Fresenius Kabi launches a new 100 mcg per 2 mL fentanyl citrate prefilled syringe to enhance patient safety
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Nutriband Inc.
    • 13.4.2. Hikma Pharmaceuticals PLC
    • 13.4.3. Teva Pharmaceutical Industries Ltd.
    • 13.4.4. Pfizer Inc.

Companies Mentioned

  • 1. Alvogen
  • 2. Apotex Inc.
  • 3. Biesterfeld SE
  • 4. Daiichi Sankyo Company, Limited
  • 5. Fresenius SE & Co. KGaA
  • 6. Hikma Pharmaceuticals PLC
  • 7. Humanwell Healthcare (Group) Co., Ltd.
  • 8. Kyowa Hakko Kirin Co. Ltd.
  • 9. Mallinckrodt plc
  • 10. Nutriband Inc.
  • 11. Pfizer Inc.
  • 12. Piramal Pharma Limited
  • 13. QuVa Pharma, Inc
  • 14. SCA Pharma
  • 15. Spectrum Chemical Mfg. Corp.
  • 16. Terumo Corporation
  • 17. Teva Pharmaceutical Industries Ltd.
  • 18. Tofigh Daru Research & Engineering Company
  • 19. Verve HumanCare Laboratories
  • 20. Viatris Inc.

LIST OF FIGURES

  • FIGURE 1. FENTANYL MARKET MULTI-CURRENCY
  • FIGURE 2. FENTANYL MARKET MULTI-LANGUAGE
  • FIGURE 3. FENTANYL MARKET RESEARCH PROCESS
  • FIGURE 4. FENTANYL MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL FENTANYL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL FENTANYL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FENTANYL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL FENTANYL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES FENTANYL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES FENTANYL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. FENTANYL MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. FENTANYL MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. FENTANYL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL FENTANYL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FENTANYL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FENTANYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FENTANYL MARKET DYNAMICS
  • TABLE 7. GLOBAL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FENTANYL MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FENTANYL MARKET SIZE, BY LOZENGES & TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FENTANYL MARKET SIZE, BY NASAL SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FENTANYL MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FENTANYL MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FENTANYL MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FENTANYL MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FENTANYL MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FENTANYL MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FENTANYL MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FENTANYL MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FENTANYL MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FENTANYL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FENTANYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FENTANYL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC FENTANYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FENTANYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM FENTANYL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM FENTANYL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM FENTANYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM FENTANYL MARKET SIZE, BY MEDICAL USE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM FENTANYL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. FENTANYL MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 236. FENTANYL MARKET, FPNV POSITIONING MATRIX, 2024